1. Home
  2. Technology
Research and Develop Innovation Platform Innovative Drugs Research and Development Pipeline
C019199 pieces
2026-03-11

C019199 pieces

C019199 is an innovative drug candidate developed by the company, designed as a new-generation therapy targeting the the tumor immunosuppressive microenvironment.
More
HXP056
2026-03-11

HXP056

The HXP056 is an oral small-molecule drug candidate for the treatment of retinal diseases, intended for conditions such as wet age-related macular degeneration (wAMD), diabetic macular edema (DME), and retinal vein occlusion (RVO).
More
About Us
Technology
Product
News
Investor
Attract Talents
Contact Us

Fujian Haixi New Pharmaceutical Creation Co., Ltd. Fujian ICP Record No. 12015727 Internet Drug Information Service Qualification Certificate No.: (Min) - Non-operating-2023-0063

Some of the text and pictures on this site are from the Internet and are only used for sharing and learning. If your rights and interests are infringed, please inform us in time, and this site will deal with or replace them in time.